Pharmacokinetics of Peptide Mediated Delivery of Anticancer Drug Ellipticine
Figure 4
Representative chromatograms of (A) blank plasma; (B) plasma added with EPT (1.56 µg/mL) and IS (dexamethasone sodium phosphate, 2.5 mg/mL); (C) plasma sample after intravenous injection of EPT (3 h); (D) plasma sample after intravenous injection of EAK-EPT (3 h).